Ad Hoc Member, NIH ZRG1 EMNR-B(02) Study Section, December 2009. Applicant investigators and institutional officials must not communicate directly with study section members about an application before or after the review. 2016/10 ZRG1 IDM-W 50 (R) US - China Program for Collaborative Biomedical Research. Member, Government and Public Affairs Committee, Society for Neuroscience, 2017- present. May 2010 Member, NIH study section ZRG1 CB-B. MSFC Study Section, June 11-12, 2015 12. 2011 Bacterial Pa thogenesis Special Emphasis Panel, NIH -201201 ZRG1 IDM A80—October 20- 21, 2011. Lung Cellular, Molecular, and Immunobiology Study Section 2010. ZRG1 HDM-Y (55) R Study Section. RNM Diagnostic Radiology Study Section 1/15/2001 ZRG1 DMG (33) Center for Scientific Review SEP 1/14/2001 ZNS1 SRB-S (02) NINDS SEP 12/11/2000 NST Neurological Sciences Training Initial Review. In addition he is the Director of Center for Integrative Toxicology. DNA (Deoxyribonucleic Acid) Metabolism. October 2014 AD hoc member NIH Mechanisms of Sensory, Perceptual, and Cognitive Processes (SPC) Study Section, June 2014 Referee Grants: National Science Foundation, National Institutes of Health,. Didier Portilla, MD Member, Pathobiology Idney Disease Study Section 2008-2012. " — Jeremy Luban, M. Be careful to accurately capture all formatting (e. Member, Neurotoxicity and Alcohol Study Section, 2006. Professor of Psychology and Neuroscience Role. Temporary member of NTRC study section (NIH), 2009, February and October meetings Ad hoc, mail reviewer, ZRG1 MDCN A (NIH, challenge grants), 2009 NIH Special Emphasis Panel (SEP, MDCN-A(05)M) teleconference, March 2011 NIH Special Emphasis Panel (ZRG1 MDCN-N 04) teleconference, June 2012. His interests include elucidation of the molecular mechanisms for impairment of signal transduction cascades and gene expression during lymphocyte activation by drugs and chemicals; mechanism for immune modulation by cannabinoid compounds. 2017/01 ZAI1 JRR-M (J1) Special Emphasis Panel. 2013 - 2015: Member, Executive Committee. Member, Special Emphasis NIH Review Panel, 10 ZRG1 IFCN -K (55) R, 2019. At first, the Commons may show your integrated review group instead of your study section. NIH, October 2011, Co-Chair of study section for Healthcare Delivery and Methodologies ZRG1 HDM-T (90) S; NIH, October 2011, study section member for Healthcare Delivery and Methodologies IRG [HDM] ZRG1 HDM-Q (54) NIH, February 2011, study section member for Special Emphasis Panel/Scientific Review Group 2011/05 ZRG1 HDM-G (02) M; NIH/CDC, June. NIH CSR Study Section ZRG1 IFCN-A (02) M. STUDY SECTIONS - GRANT REVIEWING 1. Professor of Neuroscience. 2014 October Member (Ad-hoc), Diseases and Pathophysiology of the Visual System (DPVS) Study Section, Center for Scientific Review (CSR); NIH. The Molecular and Cellular Substrates of Complex Brain Disorders Special Emphasis Panel ZRG1 MDCN-P (57) reviews applications at the interface between molecular and cellular mechanisms and brain disorders for which the basic neurobiological mechanisms, causative genetic factors, and pathological markers associated with the disorder remain uncertain. The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on. 2011-2017 NIH MSFC study section, permanent member 2011 BBS Research Council, UK, reviewer 2010 NIH ZRG1 BCMB (02) M study section, member 2010 NIH ZRG1 BCMB-B study section, member 2010 NIH ZGM1 CBB-3 (MP) study section, member 2010 NSF CHE study section, reviewer 2010 Wellcome Trust, UK, reviewer. Member, ZRG1 IMM, 2005. Suo became a Jane Coffin Childs Memorial Fund Postdoctoral Fellow for two years in the laboratory of Christopher T. 2003-2004 Member, Respiratory Physiology (RESP) Study Section, NIH 2003 Ad Hoc Member, Special Emphasis Panel (ZRG1 CII 04, Drug Resistance), NIH 2003-2006 Member, Respiratory Integrative Biology and Translational Research (RIBT) Study Section, NIH 2004 Ad Hoc Member, Special Review Committee (ZRG1 MOSS D04 for Muscle Related. She also served as co-chair of the NIH ZRG1 CB-L (50) Study Section for New Investigator MIRA grants and as chair of the NIH UO1 Glycoscience Common Fund Study Section. 2012 December Member (Ad-hoc), Study Section (Panel/SRG 2013-01 ZGM1 TWD-7);. ZRG1 BDA-A (58) Member 2009 NIH Special Emphasis Panel ZRG1 PSE-E (02) M Member 2009 NIH Special Emphasis Panel ZAG1 ZIJ-9 (J4) Member 2010 NIH Neurological, Aging and Musculoskeletal Epidemiology study section Ad-hoc member 2010 NIH Special Emphasis Panel ZRG1 BDCN T(02) Member 2010 NIH Special Emphasis Panel ZRG1 PSE-K (55) R Member. 2021 Member of the NIH Study Section on Radiation Therapy and Biology (RTB) SBIR/STTR - ZRG1 OTC1-R(11) 2020-2021 Member of the NIH Study Section on Academic-Industrial Partnerships for Translation of Medical Technologies – SBIB Q57; 2019-2020 Member of the NIH Study Section on Small Business: Medical Imaging – SBIB (10). After graduate studies, Dr. R24 Canine Longevity Consortium. Member, ZDK1 GRB-4 M, 2005. Reviewer, NIH, Special Emphasis Panel/Scientific Review Group 2017/05 ZRG1 HM-A (02) S meeting. July 2009 Member, NIH study section “Expanding the Chemical Space for Carbohydrates" Oct. AHRQ Review Study Section Jean-Pierre N. 2010-2014 Chair of Brain 3, AHA National Innovative Research Grant (IRG) study section 2013-2019 NIH ZRG1 CMBG study section, regular member 2015-present AHA Peer Review Committee member, Brain 3 2015-present Dept. MSFC Study Section, September 28-30, 2016 14. Applicant investigators and institutional officials must not communicate directly with study section members about an application before or after the. Integrated Review Groups (IRGs) are clusters of study sections based on scientific discipline. 2016 Member, Research Resource for Microscopy Image Data Analysis (ZRG1 BST-H (40)). 2000-05 Editorial Board of Cell Motility and the Cytoskeleton. National Institutes of Health, F31/F32 review panel ZRG1 F04A-D (20) L, July 2020. ZRG1 BCMB-N (50) 04/01/2020 - 04/03/2020 MEETING ROSTER RFA-RM-16-005: 2020 Pioneer Award Review Notice of NIH Policy to All Applicants: Meeting rosters are provided for information purposes only. 2012 Member, NIGMS National Centers for Systems Biology (ZGM1-CBB--MI) 11/2012. • Impact of Microbial Interactions on Infectious Diseases, ZRG1 SSS-J 02 1, Nov. CSR also receives all grant applications for NIH, as well as for some other components of the U. Failure to observe this policy will create a serious breach of integrity in the peer review process, and may lead to actions outlined in NOT-OD-14-073 and NOT-OD-15-106, including removal of the application from immediate review. Ad Hoc Reviewer, NIH NIDCR Special Grants Review Study Section June 2012 Review of P01 grant for the NIH National Institute on Aging, July 2008 Reviewer for ZRG1 MOSS D82 for AREA grant applications by Internet Assisted Meeting (IAM), October 19, 2016 National Science Foundation SBIR/STTR Merit Review Panel, Arlington, VA, April 6, 2007. March 19, 2018. Send A Message. 2112/01 Council ZES1 LWJ-J DI 2, 10/24/2011 2010 Developmental Brain Disorders Study Section - NIH ZRG1-BDCN-I(03). 22-23 2000: SSS-3 Study Section Review Panel, National Institutes of Health 2000: WHO Regional Office for Europe, Copenhagen, Denmark. For example, enter "CAMP" for the Cancer Molecular Pathobiology study section or enter text formatted like "ZRG1 HDM-R (11) B" for an SBIR/STTR panel. ZRG1 07/13/21 - 07/13/21 Meeting Roster. Biosensors, ZRG1 ETTN-C (10), 03/2018 NIH Study Section – Neuroscience and Ophthalmic Imaging Technologies (NOIT), 02/2016 NIH Special Emphasis Review Panel ZRG1 ETTN-L 53 R, PAR13-137: Bioengineering Research, 02/2016 NIH Special Emphasis Review Panel for National Heart, Lung, and Blood Institute, ZHL1 CSR-I (O1), 08/2014. NIH CSR Study Section ZRG1 IFCN-A (02) M. Sydney Burwell Associate Professor of Medicine. - Permanent Member Virology B Study Section, NIH, 2/2004-6/2006. Farmington, CT 06030-3401. 2013 - 2014. Member, NIH Study section: ZRG1 IDM-L 55R, OD-10-005 Directors Opportunity Infectious Diseases B. 2000-04 Study Section Member, for Cell Development and Function-4 (CDF-4) NIH/NIGMS. Study Section Special Emphasis Panel (ZRG1-BBBP-4 (01)) Program Officer Buckholtz, Neil. 1999: Special Study Section for Program Project, ZRG1 SSS-2, NIH, April 6-7. NIH, ZRG1 F05 study section reviewer (NRSA Fellowships in Cell Biology and Development) (2005, 2007, 2008) Austrian Science Fund (FWF - Fonds zur Förderung der Wissenschaftlichen Forschung Biologie & Medizin) proposal reviewer (2006) NIH, BDPE study section reviewer (2005). Failure to observe this policy will create a serious breach of integrity in the peer review process,. NIGMS Minority Biomedical Research Support (MBRS) SCORE (Support Competitive Research) program. Kaminski is a Professor at Pharmacology & Toxicology. com and suggest new type of analysis. Room 3902 South Building, CB 8103. See full list on grants. January 26 - 27, 2017. Science Vocabulary - Section 1. Greenberg, M. 2017 Scientific Reviewer, Society of Behavioral Medicine Abstract Review Committee. 3/14, DC; NIH, Study Section, Nanotechnology (NANO), 5/13 and 9/12, Special Emphasis Panel/Scientific Review Group ZRG1 ETTN-P -(50) R PAR-11-304, Development of Appropriate Pediatric Formulation and Drug Delivery Systems, 3/12, CA and NIH, Special Emphasis. ZRG1 BCMB-S (40) Study Section, July 14-16, 2015 13. 2004-2007 Study Section on Carcinogenesis, Nutrition, and Environment, American Cancer Society. October 2014 Member, Grant Review Committee, National Institutes of Health (NIH): III (Innate Immunity And Inflammation) Study Section. 2 : Special panel ZRG1 DKUS-A 58 2009. 2012 Ad-Hoc Reviewer, ZRG1 IDM-R (02) M (Parasites and Vectors Study Section), National Institutes of Allergy and Infectious Disease 2012 External Grant Reviewer, Rhode Island Research Alliance Collaborative Research. During the next few days, CSR will update this information with the study section assignment. United Mitochondrial Disease Foundation study section co-chair (2011-2015), NIH ZRG1 ETTN-G (2013), Chronic Fatigue Initiative review panel (2014-2015). March 2015 Member Grant Review Committee, National Institutes of Health (NIH): ZRG1 F15-P20 Surgical Sciences, Biomedical Imaging and Bioengineering Study Section. 2011: Member, NIH Study Section: ZRG1 AARR-C 02, Member Conflict applications for several Study Sections within the AIDS and Related Research IRG. 2000–05 Editorial Board of Cell Motility and the Cytoskeleton. Chair, NIH AITRC Study Section, 2011-2015. BUDGET RECOMMENDATIONS section. Member, Special Study Section 7, National Institutes of Health (1995) Member Ad hoc, Biophysical Chemistry Study Section BBCB, NIH (1996) Member, NIH Special Emphasis Review Panel, ZRG1 SSS-A (2002) Member, NIH Special Emphasis Panel, ZRG1 BPC-L 30, NMR S10 (2004) Member, NIH Special Emphasis Panel, ZRG1 F04B 20 L, Fellowships (2005). Member for NIH MSFA study section (2020-2024) ad hoc reviewer for NIH panels ZRG1 Study Section (Small Business: Biological Chemistry and Biophysics) 2016 and 2018. National Institutes of Health/NCI ZRG1-OBT R21 Study Section, Committee Assistant Chair: 2019: National Institutes of Health/NCI ZRG-F09A F30/31/32 Fellowships: Oncology Study Section, Ad Hoc Member: 2020: National Institutes of Health/NCI Tumor Cell Biology Study Section, Ad Hoc Member: National Committees (Permanent Member) 2002-2005. Study Section [SYN] Reviewer 2016 NIH 2017/01 ZRG1 MDCN-R, R15, special emphasis panel Reviewer P. SBIR Grant ZRG1 NIH/NIAID; Ad hoc Study section NIH NIAID’s Microbiology and Infectious Diseases B Subcommittee (MID-B). 2010 NIH, CMND Study Section, February and May meetings. Center for Scientific Review (CSR) Study Sections and Special Emphasis Panels Applications are reviewed in Study Sections (Scientific Review Groups, SRGs) or Special Emphasis Panels (SEPs). 1R15AI126395-01A1 Mir, Mohammad. Member, Special Study Section 7, National Institutes of Health (1995) Member Ad hoc, Biophysical Chemistry Study Section BBCB, NIH (1996) Member, NIH Special Emphasis Review Panel, ZRG1 SSS-A (2002) Member, NIH Special Emphasis Panel, ZRG1 BPC-L 30, NMR S10 (2004) Member, NIH Special Emphasis Panel, ZRG1 F04B 20 L, Fellowships (2005). - NIH Study Section ZRG1 FO6 Endocrinology, Metabolism, Nutrition and Reproductive Sciences NRSA Review member, 2003-4 - NIH Study Section ZRG1 SSS3-T10B Innovation Research Metab/Diabetes 2003 Cystic Fibrosis Foundation - Faculty, CFRD Learning and Leadership Collaborative, 2010-11 - Ad Hoc grant reviewer, TDN, 2010 PROFESSIONAL SERVICE. Chairman, Pathobiology Kidney Disease Study Section: ZRG1 DKUS-A (Aug 22, 2011) Adhoc, NIH/NHLBI Program Project, December 14, 2011 Expert Panel, NIDDK AKI Outcomes: Overcoming the Barriers in Acute Kidney Injury 2015. Member 2010/05 ZDK1 GRB-6 (M1) 1 - Energy Balance Program Projects, National Institutes of Health. NIH - ZRG1 IDM W02 Study Section, Topics in Virology; Reviewer -mAd hoc (2020) JSMBS Faculty Council Steering Committee (2020-present) JSMBS Executive Committee (2020-present) Dean's Executive Committee (2020-present) Faculty Council Steering Committee (2020-present) PLOS Pathogens (2020) Journal of Virology (2020) PLOS One (2020). Abstract Reviewer Heart Rhythm Society. Scientific Board, Trudeau Institute, 2012-2016. 2010 NIH, ZRG1 MDCN-G(91) Study Section. 2017 Scientific Reviewer, Society of Behavioral Medicine Abstract Review Committee. The Biostatistical Methods and Research Design (BMRD) Study Section reviews applications which seek to advance statistical and mathematical techniques and technologies applicable to the experimental design and analysis of data in biomedical, behavioral, and social science research. 2008: NINDS, study section ZNS1 SRB-S. 2016/10 ZRG1 IDM-W 50 (R) US – China Program for Collaborative Biomedical Research. National Institute of Biomedical Imaging and Bioengineering; Program Project Grant Review; Point‐of‐Care Nanodiagnostics. The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on. Chair, NIH AITRC Study Section, 2011-2015. 2010 Committee Service. Chair, Special Emphasis Review NIAID Panel, 2015. (February 2000). Today, as the flagship of the state's 13-campus university system, University of Maryland, College Park is home to more than 41,000+ students, 4,440+ faculty, and 250 academic programs. 215E Bonner Hall. 2015 NIH, NIDDK, ZRG1 DKUS-N (10) Study Section Member 2015 NIH, NIDDK, ZTR1 CI-8 (01) Study Section Member C. Study Sections Applications are reviewed in study sections (Scientific Review Group, SRG). The Exploration of Antimicrobial Therapeutics and Resistance Study Section reviews applications that would otherwise be reviewed by the Drug Discovery and Mechanisms of Antimicrobial Resistance (DDR) study section. Member, Special Emphasis NIH Review Panel, 08 ZRG1 IFCN -K (56) R, 2019. ZRG1 CVRS A11_ Respiratory Sciences Small Business Study Section: 2020: NIH: ZRG1 CVRS-J (11) Small Business: Respiratory Sciences: 2020: NPR: How ICU Doctors Balance Patients, Parenting: WSHU: How ICU Doctors Balance Patients, Parenting, April 7, 2020: 2020: Society of Anesthesia and Sleep Medicine, Orlando, FL: program committee chair: 2019. Member, NIH Study section: ZRG1 IDM-L 55R, OD-10-005 Directors Opportunity Infectious Diseases B. National Institute of Allergy and Infectious Diseases. ZRG1 BCMB-A (51) 03/30/2016 MEETING ROSTER RFA-RM15-005: Transformative Research Award Review Notice of NIH Policy to All Applicants: Meeting rosters are provided for information purposes only. The Molecular and Cellular Substrates of Complex Brain Disorders Special Emphasis Panel ZRG1 MDCN-P (57) reviews applications at the interface between molecular and cellular mechanisms and brain disorders for which the basic neurobiological mechanisms, causative genetic factors, and pathological markers associated with the. 2001 – 2006 – Member of the National Institute of Health Grant Review Study Section – Brain Disorders and Clinical Neuroscience 1 (BDCN-1/CND) October 2003 – Invited Participant -NIH-NINDS – Priorities for Clinical Research in the Treatment of Acute, non-Traumatic Intracerebral Hemorrhage Workshop, 2003. Member, Government and Public Affairs Committee, Society for Neuroscience, 2017- present. Reviewer for NIH/NIGMS Study Section ZRG1 MOSS D14: June 2005 4. • Senior Research Fellow and Director, Neurology Section, Neuroscience Therapeutics; December, 1999-April, 2000 • Senior Research Fellow and Group Leader, Neuropharmacology, Neuroscience Therapeutics. The Topics in Bacterial Pathogenesis Special Emphasis Panels [IDIA 80 and 81] are identical in scope and review applications that would otherwise be reviewed by either the Bacterial Pathogenesis (BACP) or Host Interactions with Bacterial Pathogens (HIBP) Study Sections. Applicant investigators and institutional officials must not communicate directly with study section members about an application before or after the review. 6 : PCD Study Section 2002. (UKGD) Study Section 2006 Member, ZRG1 RUS-A 51 1, NIDDK PAR 06 113, October 26-31 2006 Reviewer, Research Grant Management, South African Medical Research. Grant Review Panel. Find out exactly what test scorers will be looking for when then evaluate your performance on this test by checking out this study guide. 2010- Fellow, Heart Rhythm Society. , Aug, 2004. • Senior Research Fellow and Director, Neurology Section, Neuroscience Therapeutics; December, 1999-April, 2000 • Senior Research Fellow and Group Leader, Neuropharmacology, Neuroscience Therapeutics. Increased response to glutamate in small diameter dorsal root ganglion neurons after sciatic nerve injury. NIH PTHE study section (ad hoc June 2018), NIH Special Emphasis Panels ZRG1 IDM-M (02) M, PAR-14-080, ZGM1 RCB-7 (SC), ZRG1 IDM-P (02) M K-awards-MID-B, ZRG1 IDM-P (02), ZRG1 AARR-K(04), ZRG1 IDM- M (03), ZRG1 IDM-B (03), ZRG1 AARR-E (02), ZRG1 AARR-K (02) ZRG1 IDM-M (03) M, the American Heart. NIH HAI ad hoc study section member, February 4-5, 2010 NIH ZRG1 IMM-J(02)M Special Emphasis Panel, June 9, 2010 PRMRP 2010 Concept Awards, July 2010 Medical Research Council (UK) G1001193, August 2010 PRMRP 2011 Lupus Panel, September 7, 2011. Schwartz, MD, received his undergraduate and medical degrees from Harvard University, where he graduated Magna Cum Laude. National Institutes of Health, Synthetic & Biological Chemistry A study section, 2021-2025 (pending approval) National Institutes of Health, F31/F32 review panel ZRG1 F04A-V (20) L, March 2021. 10 : PBKD Study Section 2011. Buffalo, New York 14260. 2010 Service or Event Name. 2000–04 Study Section Member, for Cell Development and Function-4 (CDF-4) NIH/NIGMS. 301-435-0484. NIH Study Section ZRG1 BDCN-C(02)M, Member 2011 Scientific Review NIH T32 Institutional Research Training Grant (NIH ZMH1 ERB-S-01), Member 2011 Swiss National Science Foundation, Reviewer for Fellowships 2011- Advisory Board, Center for Research in Psychology, School of Psychology, University of Minho, Minho, Portugal, Member. 1997-1999 Chairman, National Institutes of Health Study Section, Visual Sciences B Study Section; Integrative, Functional, and Cognitive Neuroscience Initial Review Group, Washington, D. Study Sections. Be careful to accurately capture all formatting (e. 2017 Co-Chair, NIH Psychosocial Risk and Disease Prevention Study Section (PRDP), CSR Scientific Review Officer: Stacey Fitzsimmons. - Study Section UO1/ Cooperative Centers for Translational Research on. Freelander Chair in AIDS Research and Professor, Program in Molecular Medicine and Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School. ZAI-EC-M-S1 Study Section. Department of Defense (DoD): Congressionally Directed Medical Research Programs (CDMRP) Prostate Cancer Research Program Grant Review Panel 2009. Ad Hoc Member, NIH ZRG1 EMNR-B(02) Study Section, December 2009. 2000-04 Study Section Member, for Cell Development and Function-4 (CDF-4) NIH/NIGMS. (UKGD) Study Section 2006 Member, ZRG1 RUS-A 51 1, NIDDK PAR 06 113, October 26-31 2006 Reviewer, Research Grant Management, South African Medical Research. PBKD Study Section 2007. STUDY SECTIONS – GRANT REVIEWING 1. Louis, Missouri, 63110. ZRG1-IFCN-T-02 Study Section 2014. National Cancer Institute, Study Section Member 2016 ZRG1 F16-E (09) F and F16-L (20) L Fellowships (F31s and F32s): Risk, Prevention and Health Behavior National Institutes of Health, Study Section Member 2016 NCI OMNIBUS R03 ZCA1 SRB-5 (O1) National Cancer Institute, Study Section Member 2018 NCI ZRG1 OTC-W (55) R. Member, ZRG1 IMM, 2005. About the University. See full list on grants. Member, Special Emphasis NIH Review Panel, 10 ZRG1 IFCN -K (55) R, 2019. Department Type DUNS #. Contributions to Science: 1. 2008: Top Doctors, New York Metro Area, Castle Connolly 2010: NIH Study Section ZRG1 ETTN-B. December, 1997-December, 1999 • Adjunct Professor of Pharmacology, Northeastern Ohio Universities College of Medicine. After graduate studies, Dr. NIH 2015/10 ZRG1 BBBP-Y (45) RFA Panel: Animal/Biological Resource Facilities Study Section (Scientific Review Group, SRG), 2015 US Department of Justice – Office of Justice Program. Grant applications that focus on developing novel high throughput screens for small molecule hits and immunotherapeutics may be reviewed in BST (55). Member 2010/05 ZDK1 GRB-6 (M1) 1 - Energy Balance Program Projects, National Institutes of Health. 2009 NIH, ZRG1 CB-Q (30) Study Section. Small Business Special Emphasis Panel [ZRG1 DKUS-N(10) B] Study Section in Digestive Diseases: 2015 - 2019: AASLD: Review Committee Member, Award/fellowship application for the American Association for the Study of Liver Diseases (AASLD) 2015 - 2017: AASLD: Review committee member, Award/fellowship application: 2015 - 2017: Hepatology International. Stage 1 Reviewer, National Institutes of Health Challenge Grant applications for ZRG1 PSE-J and ZRG1 PSE-C. Ad hoc Study section NIH Special Emphasis Panel, Pathogenic Eukaryotes (PTHE). Contributions to Science: 1. French National Research Agency, Action Medical Research UK, NIH HBPP study section NIH Special Emphasis Panel ZDK1 GRB-7 (O2) 1; NIH Special Emphasis Panel ZRG1 DKUS-C 82 A; NIH XNDA. 2001 Gender Equity Award for promoting a gender-fair environment for the education and training of women physicians and assuring equal opportunity for women and men to study and practice medicine. National Cancer Institute, Study Section Member 2016 ZRG1 F16-E (09) F and F16-L (20) L Fellowships (F31s and F32s): Risk, Prevention and Health Behavior National Institutes of Health, Study Section Member 2016 NCI OMNIBUS R03 ZCA1 SRB-5 (O1) National Cancer Institute, Study Section Member 2018 NCI ZRG1 OTC-W (55) R. National Institutes of Health, F31/F32 review panel ZRG1 F04A-D (20) L, July 2020. 1997-1999 Chairman, National Institutes of Health Study Section, Visual Sciences B Study Section; Integrative, Functional, and Cognitive Neuroscience Initial Review Group, Washington, D. Hawden Foundation, United Kingdom 2016 Grant Reviewer for Wellcome Trust, United Kingdom. Member, Special Emphasis NIH Review Panel, 10 ZRG1 IFCN -K (55) R, 2019. 2001 - 2007. Professor of Psychology and Neuroscience Role. Ad Hoc Member, NIH ZRG1 EMNR-B(02) Study Section, December 2009. Permanent Member, NIH Neurobiology of Learning and Memory Study Section, 2017- present. 2005 NIH study section. ZRG1 AARR-N (56) Study Section. Subsequently, Dr. in the Center for Advanced Medicine (CAM), Farrell Conference Room 2. July 2014 Member, Scientific Advisory Committee. National Institutes of Health/NCI ZRG1-OBT R21 Study Section, Committee Assistant Chair: 2019: National Institutes of Health/NCI ZRG-F09A F30/31/32 Fellowships: Oncology Study Section, Ad Hoc Member: 2020: National Institutes of Health/NCI Tumor Cell Biology Study Section, Ad Hoc Member: National Committees (Permanent Member) 2002-2005. March 2015 Member Grant Review Committee, National Institutes of Health (NIH): ZRG1 F15-P20 Surgical Sciences, Biomedical Imaging and Bioengineering Study Section October 2014 Member, Grant Review Committee, National Institutes of Health (NIH): III (Innate Immunity And Inflammation) Study Section. Vice Chair Study Section, Stage 2 Editorial Board for Special Emphasis Panel ZDK1 GRB-J M1, National Institutes of Health. 2010 NIH, ZRG1 MDCN-G(91) Study Section. 2010: Chairperson, NIMH, ZMH1 ERB-L (02) study section. Susanna Rosi, PhD Associate Professor Brain and Spinal Injury Center 1001 Potrero Ave, Bldg. 2010 NIH ZRG1 BCMB-B study section, member 2010 NIH ZGM1 CBB-3 (MP) study section, member 2010 NSF CHE study section, reviewer 2010 Wellcome Trust, UK, reviewer 2009 NIH ZRG1 BCMB-U (P01) review panel, member 2009 NSF CHE study section, reviewer. ZRG1 02/13/20 - 02/13/20 Meeting Roster. Service Performed By. 2007 Ad hoc reviewer on Study Section of ZRG1 NOMD-A (Neural Oxidative Stress, Mitochondria and Cell Death), National Institute of Health 2007 Review Panel F, Alzheimer's Disease Research Program, Department of Health Services, California. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes. ZRG1 OBT-A (55) R, Recovery Act Limited Competition. Ad-hoc Reviewer, NIH/NIAID RFA-AI-09-015 Study Section ZAI1-MFH-I-J2 "Coordinating Center for Organ Transplant Clinical Trials" October 23, 2009. study section panel name meeting rosters; zai1 sb-i(s1) cohort studies to improve our understanding of influenza immunity, vaccine response and effectiveness in older adults (65 years and older) (u01 clinical trial not allowed) 07/09/21: zai1 esb-m(s1). Study Section [SYN] Reviewer 2016 NIH 2017/01 ZRG1 MDCN-R, R15, special emphasis panel Reviewer P. NIH CSR Study Section ZRG1 IFCN-A (02) M. NIH 2015/10 ZRG1 BBBP-Y (45) RFA Panel: Animal/Biological Resource Facilities Study Section (Scientific Review Group, SRG), 2015 US Department of Justice – Office of Justice Program. • Impact of Microbial Interactions on Infectious Diseases, ZRG1 SSS-J 02 1, Nov. 1 was conducted before the current pandemic began. • NIDCD Otitis media RFA-DC-02-002 Study Section, 2002 and 2003. 2013: ZAI1 LR -M (P01 program project grant), ZRG1 IMST L. For example, you would enter CAMP if you wish to request assignment to the Cancer Molecular Pathobiology study section or enter ZRG1 HDM-R if you wish to request assignment to the Healthcare Delivery and Methodologies SBIR/STTR panel for informatics. NIJ Peer Review Graduate Research Fellowship. 2000 Ad Hoc Reviewer, ZRG1 IFCN-1(03) CSR Special Emphasis Panel, National Institute of Health, Bethesda, Maryland. Jamal Ibdah of University of Missouri Health's School of Medicine", January 2016. Panel member in the past 10 year s: 11/20/2020 Member, NIH/EHS Review Committee ZES1 VSM-S(t) for T32 training grants. 2 : CSD Study Section 2006. 2011: Chair, Fellows Council, Society of Vascular Surgery. NIH Study Section ZRG1 BDCN-C(02)M, Member 2011 Scientific Review NIH T32 Institutional Research Training Grant (NIH ZMH1 ERB-S-01), Member 2011 Swiss National Science Foundation, Reviewer for Fellowships 2011- Advisory Board, Center for Research in Psychology, School of Psychology, University of Minho, Minho, Portugal, Member. Tetrahedron 1995, 51, 29. 2017 Co-Chair, NIH Psychosocial Risk and Disease Prevention Study Section (PRDP), CSR Scientific Review Officer: Stacey Fitzsimmons. com and suggest new type of analysis. 1996-2016: Listed in "Best Doctors in America". NIH PTHE study section (ad hoc June 2018), NIH Special Emphasis Panels ZRG1 IDM-M (02) M, PAR-14-080, ZGM1 RCB-7 (SC), ZRG1 IDM-P (02) M K-awards-MID-B, ZRG1 IDM-P (02), ZRG1 AARR-K(04), ZRG1 IDM- M (03), ZRG1 IDM-B (03), ZRG1 AARR-E (02), ZRG1 AARR-K (02) ZRG1 IDM-M (03) M, the American Heart. Delta Omega Honor Society for Public Health, 2014. study section panel name meeting rosters; zai1 sb-i(s1) cohort studies to improve our understanding of influenza immunity, vaccine response and effectiveness in older adults (65 years and older) (u01 clinical trial not allowed) 07/09/21: zai1 esb-m(s1) niaid investigator initiated program project applications (p01 clinical trial not allowed). Annual Meeting, Boston, Massachusetts, February 28 - March 4, 2009. 2001 - 2007. Member, Special Emphasis NIH Review Panel, 08 ZRG1 IFCN -K (56) R, 2019. NIH ZRG1 F03A (20), Fellowships: Neurodevelopment, Synaptic Plasticity, Neurodegeneration Study Section, Oct 2017, March 2018, and June 2018 Discussion Leader/Session Co-Chair. Be careful to accurately capture all formatting (e. NIH CSR Pregnancy and Neonatology (PN) Study Section, 10/2016 NIH CSR Special Emphasis Panel, PAR13-309-311: Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics, ZRGI EMNR-S, 6/2016. Study Section Study Section Description Scientific Review Officer Date; ZRG1 ACTS-L 07 Oct 2021 Arthritis, Connective Tissue and Skin Sciences : Dr. Chair, Special Emphasis NIH Study Section ZRG1 PSE H(59) R. University of Washington, Seattle, WA. She also served as co-chair of the NIH ZRG1 CB-L (50) Study Section for New Investigator MIRA grants and as chair of the NIH UO1 Glycoscience Common Fund Study Section. ZRG1 TTT-G “Immunology of Tolerance” Study Section, NIH: Special Emphasis Allergy and Immunology Study Section, NIH: Study Section: Ad Hoc Grant Reviewer. (March 2000). NIH CSR Study Section ZRG1 IFCN-A (02) M. 2 : PBKD Study Section 2011. Integrated Review Groups (IRGs) are clusters of study sections based on scientific discipline. Chair and Reviewer, NIH CSR Endocrinology, Metabolism, Nutrition and Reproductive Sciences Small Business/Technology Transfer (SBIR/STTR) Study Section, Special Emphasis Panel, NIH CSR ZRG1 EMNR-S 11 B, 12/2013. Member, Neurotoxicity and Alcohol Study Section, 2006. 2001 Gender Equity Award for promoting a gender-fair environment for the education and training of women physicians and assuring equal opportunity for women and men to study and practice medicine. Department Psychology Type Schools of Arts and Sciences. 2000-2008 Member, ZRG1 F10 Study Section, NIDDK 2000-2003 Member, GI Advisory Committee, U. 2012: Member, NIH/NIMHD/CSR Research Program (RO1) Study Section ZMD1 MLS (01) 2012: Ad Hoc Member, NIH/NHLBI/CSR Special Emphasis Panel 2012/10 ZRG1 VH-D (90) S: Vascular and Hematology 2011-2016: Regular Member, AHA Vascular Endothelial Biology and Function Study Section. 2001-2003 Member of the Harbor Consortiu m by New York Academy of Science and New York City Health Department. 1985 - 1987 Research Associate, Section of Physical Anthropology, IVPP,. NIH PTHE study section (ad hoc June 2018), NIH Special Emphasis Panels ZRG1 IDM-M (02) M, PAR-14-080, ZGM1 RCB-7 (SC), ZRG1 IDM-P (02) M K-awards-MID-B, ZRG1 IDM-P (02), ZRG1 AARR-K(04), ZRG1 IDM- M (03), ZRG1 IDM-B (03), ZRG1 AARR-E (02), ZRG1 AARR-K (02) ZRG1 IDM-M (03) M, the American Heart. 2010 Member, NIH study section ZRG1 BCMB-B. 1999: Special Study Section for Program Project, ZRG1 SSS-2, NIH, April 6-7. In addition he is the Director of Center for Integrative Toxicology. Intramural NHLBI Review Committee, 2014. Basic unit of life. Delta Omega Honor Society for Public Health, 2014. 2013 • NIH Study Section, National Institute for Diabetes, Digestive, and Kidney Diseases Special. 2004 Mail Reviewer: for South Carolina NASA/EPSCoR Research Grant Program 2004 Mail Reviewer: for CSR Skeletal Biology Development and Disease (SBDD) study section R21 grant applications, June 27. Applications are reviewed in study sections (Scientific Review Group, SRG). 2012 Member, Mail Reviewer, NIH special emphasis panel. Scientific Board, Trudeau Institute, 2012-2016. 2014 Study Section, ZRG1 DKUS-N; Digestive Sciences. ZRG1 OBT-A (55) R, Recovery Act Limited Competition. The research team wanted to use their data to determine whether probability of getting COVID depends on a person’s sex, where they live, and also the diversity of their lung microb i ome. Search, browse and learn about the Federal Register. 2020 Ad hoc NIH ZRG1 CBA (50) study section panel member 2020 Ad hoc NIH NCSD study section panel member 2019 Reviewer for NSF MCB Genetic Mechanisms. MSFC Study Section, October 5-6, 2017 Additional Grant Review Activity 1. Reviewer for NIH/NIGMS Study Section ZRG1 BDMA (Biodata management and analysis): Mar 2004, Jun 2004. 2012: Ad Hoc Member, NICHD, CHHD-C 2 Developmental Biology Subcommittee, 4/2012 2012: Ad Hoc Member, NIH ZRG1 F06-T 20 Fellowship: Endocrinology, Metabolism, Nutrition and. NIH Ad hoc reviewer and Chair: Special Emphasis Panel/Scientific Review Group ZRG1 MOSS-S (02) Study Section, 2017 2017-2018 AADR Edward H. NIH study section Drug Discovery and Probes for the Nervous System ZRG1 MDCN B from BIOLOGY 3040 at Boston College. 2002 2006: Member, Medicinal Chemistry (MCHA/SBCA) Study Section. Koman for the Cure Research Program. Walsh at Harvard Medical School. Study Section. of Veterans Affairs DVA Review Committee member (Neurobiology C). 1997-1999 Chairman, National Institutes of Health Study Section, Visual Sciences B Study Section; Integrative, Functional, and Cognitive Neuroscience Initial Review Group, Washington, D. NIH - ZRG1 IDM W02 Study Section, Topics in Virology; Reviewer -mAd hoc (2020) JSMBS Faculty Council Steering Committee (2020-present) JSMBS Executive Committee (2020-present) Dean's Executive Committee (2020-present) Faculty Council Steering Committee (2020-present) PLOS Pathogens (2020) Journal of Virology (2020) PLOS One (2020). Sydney Burwell Associate Professor of Medicine. 2017 Scientific Reviewer, Society of Behavioral Medicine Abstract Review Committee. LIFESPAN)” Study Section, Nov 2011- Jan 2012 NIH Director’s Pioneer Award Study Section, Dec 2011 - Jan 2012 Co-Chair, NIH ZRG1 PSE-K (03) Social Science and Population Studies SEP, Sept-Oct 2011. NIH Study Section: ZRG1 BST-M (58) R, RFA OD-09-003, Challenge Grants Panel 4 (2009). March 2017 Study Section, ZRG1 DKUS J, Physiological & Pathological Sciences. 11/09/11-11/10/11 NIH Environmental Health Sciences Review Committee. com and suggest new type of analysis. 2112/01 Council ZES1 LWJ-J DI 2, 10/24/2011 2010 Developmental Brain Disorders Study Section - NIH ZRG1-BDCN-I(03). 2013: ZAI1 LR -M (P01 program project grant), ZRG1 IMST L. 10 : PBKD Study Section 2011. ZRG1 HDM-Y (55) R Study Section. 2010: President, Medical. 2016/05 ZRG1 BCMB-U 50 (R) Facile Methods and Technologies for Synthesis of Biomedically Relevant Carbohydrates. NIH Ad hoc reviewer and Chair: Special Emphasis Panel/Scientific Review Group ZRG1 MOSS-S (02) Study Section, 2017 2017-2018 AADR Edward H. French National Research Agency, Action Medical Research UK, NIH HBPP study section NIH Special Emphasis Panel ZDK1 GRB-7 (O2) 1; NIH Special Emphasis Panel ZRG1 DKUS-C 82 A; NIH XNDA. Kutateladze 3. 3 - Reviewer for NIH Grant Study Section, Special Emphasis Panel/Scientific Review Group 2007/05 ZRG1 CFS-E (01) meeting, March 2007 - Best Poster Presentation at the American Academy of Orofacial Pain Meeting, April 2006. Delta Omega Honor Society for Public Health, 2014. 2009 Member, NIH study section ZRG1 BCMB. 2001 - 2006 - Member of the National Institute of Health Grant Review Study Section - Brain Disorders and Clinical Neuroscience 1 (BDCN-1/CND) October 2003 - Invited Participant -NIH-NINDS - Priorities for Clinical Research in the Treatment of Acute, non-Traumatic Intracerebral Hemorrhage Workshop, 2003. PBKD Study Section 2007. At first, the Commons may show your integrated review group instead of your study section. The Molecular Neuropharmacology and Signaling (MNPS) Study Section reviews both hypothesis-driven and discovery-based applications on neurotransmitter and receptor signal transduction with a focus on neurochemical, neuroendocrine and molecular neuropharmacological mechanisms. Ad Hoc NIH Service: 2014: NANO (Summer). " All suggestions will be considered; however, not all assignment suggestions can be honored. 1997-1999 Chairman, National Institutes of Health Study Section, Visual Sciences B Study Section; Integrative, Functional, and Cognitive Neuroscience Initial Review Group, Washington, D. Room 3902 South Building, CB 8103. study section panel name meeting rosters; zai1 sb-i(s1) cohort studies to improve our understanding of influenza immunity, vaccine response and effectiveness in older adults (65 years and older) (u01 clinical trial not allowed) 07/09/21: zai1 esb-m(s1) niaid investigator initiated program project applications (p01 clinical trial not allowed). Study Section. 2013 - 2014. Ad Hoc Expert Reviewer ZRG1 PSE-A (02), National Institutes of Health. Ad hoc member of Special Study Section to Review proposal for Centers of Excellence in Chemical Methodologies and Library Development, NIH, Washington, D. Benzylic Stabilization as a Mechanistic Tool for Studying Radical Rearrangements. Study Sections. Study Sections Applications are reviewed in study sections (Scientific Review Group, SRG). These study sections will be set up and run by the NIH Center for. Today, as the flagship of the state's 13-campus university system, University of Maryland, College Park is home to more than 41,000+ students, 4,440+ faculty, and 250 academic programs. Reviewer for NIH/NIGMS Study Section ZRG1 BPC‐Q and BCMB‐N (Computational biophysics): Oct 2004, Feb 2005, Feb 2007. 2010 Committee Service. NIH Study Section: ZRG1 BST-M (58) R, RFA OD-09-003, Challenge Grants Panel 4 (2009). Chair, NIH Study Section ZRG1 PSE-R (58). 2018 NIH Grant Reviewer, Glycoscience UO1 ZRG1 IMST-B (52) R Study Section 2018 Grant Reviewer, Bloodwise (UK) 2018 NIH Grant Reviewer, Intercellular Interactions (ICI) Study Section 2018 Grant Reviewer, BWH BRI Pilot and Innovation Grants Program 2018 BWH/BRI Grant Review, Smith Family Awards - Excellence in Biomed. ZRG1 MOSS-R (56) 03/13/2017 - 03/14/2017 MEETING ROSTER investigators and institutional officials must not communicate directly with study section members about an application before or after the review. Gong K, Kung L-H, Magni G, Bhargava A, Jasmin L. 22-23 2000: SSS-3 Study Section Review Panel, National Institutes of Health 2000: WHO Regional Office for Europe, Copenhagen, Denmark. Study Section Assignment Request (optional) If you have a preference for a study section assignment, please use the link below to identify the most appropriate study section then enter the short abbreviation for that study section in “Assign to/Do not Assign to Study Section” sections below. NIJ Peer Review Graduate Research Fellowship. Phone: 860-679-2241. Vice Chair Study Section, Stage 2 Editorial Board for Special Emphasis Panel ZDK1 GRB-J M1, National Institutes of Health. She also served as co-chair of the NIH ZRG1 CB-L (50) Study Section for New Investigator MIRA grants and as chair of the NIH UO1 Glycoscience Common Fund Study Section. has been very responsive to the criticisms made by the study section. 4/2015 ZHD1 DSR-Y (MC) 1 study section 10/2014, 2/2015 NCF study section, Co-Chair 2011 NCF study section, regular member 09/2010 ZRG1 MDCN-T (03) 10/2009 DBD study section 09/2009 ZRG1 BDA-A (52)R study section 06/2009 ZRG1 MDCN-F (95)s study section 06/2009 NDPR study section 03/2009 NSD-A study section 04/2008 CHHD-C. Reviewer Interventions to Prevent and Treat Addictions (IPTA) Study Section, October 2015. MSFC Study Section, October 5-6, 2017 Additional Grant Review Activity 1. Committee Member Research Committee, Department of Pediatric and Adolescent Medicine. June, 2009. 2012 • Swiss National Science Foundation. University of Maryland was founded in 1856. Member, ZDK1 GRB-4 M3, 2006. About the University. Contact Information. Allergy and Immunology (ALY, now CMI-A) Study Section, 1984 - 2000 Immunological Sciences (IMS, now TTT) Study Section, 1985 - 1988 Education Committee, American Association of Immunologists, 1988 - 1992 ZRG1 BDCN-B (55) Review panel for Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimer. 263 Farmington Avenue. 2010 Member, NIH study section ZRG1 BCMB-B. 2000 Special Reviewer, Pathobiochemistry Study Section 2002- Member, NIH Special Emphasis Review Panel (ZRG1 BIO) 2003 Tumor Microenvironment Study Section, NIH 2006-08 Special Emphasis Panel Reviewer, NIHLB, NIH 2008 Member, External Review Panel for Molecular Biology Section, NIDCR, NIH 2009 Special Emphasis Panel/Scientific Review Group 2010. National Institutes of Health. To study these mechanisms in detail, my lab has generated in vitro models of development and disease that recreate the three-dimensional and mechanical environments of in vivo tissues. 1999 – General Medicine A-2 Study Section, National Institutes of Health, Feb. October 2014 AD hoc member NIH Mechanisms of Sensory, Perceptual, and Cognitive Processes (SPC) Study Section, June 2014 Referee Grants: National Science Foundation, National Institutes of Health,. Johnson at Pennsylvania State University. 2016 Member, Research Resource for Microscopy Image Data Analysis (ZRG1 BST-H (40)). 2012/10 NIH CMIB study section; 2013/3 NIH SEP ZRG1 IMM-C Autoimmune and Infectious Disease study section; 2014/5 NIH CMIB study section; 2014/7 NIH SEP ZRG1 IMMC02M study section; 2015/2 NIH SEP NIAID P01 initiative; 2015/5 NIH CMIB study section. 07/22/10 NIH Special Emphasis Panel on Fellowship (ZRG1 F04B-B 20 L) 02/28/11-02/28/11 NIH Cancer Etiology Study Section. List of Reviewers on 03/19/2020; List of Reviewers on 11/07/2019; List of Reviewers on 06/03/2019. Fellowships: Cell Biology, Developmental Biology, and Bioengineering. Member for NIH MSFA study section (2020-2024) ad hoc reviewer for NIH panels ZRG1 Study Section (Small Business: Biological Chemistry and Biophysics) 2016 and 2018. 2000-05 Editorial Board of Cell Motility and the Cytoskeleton. Applicant investigators and institutional officials must not communicate directly with study section members about an application before or after the review. NIH HAI ad hoc study section member, February 4-5, 2010 NIH ZRG1 IMM-J(02)M Special Emphasis Panel, June 9, 2010 PRMRP 2010 Concept Awards, July 2010 Medical Research Council (UK) G1001193, August 2010 PRMRP 2011 Lupus Panel, September 7, 2011. National Institutes of Health, Skeletal Biology Development and Disease Study Section, June 9‐11, 2006. NIH 2015/10 ZRG1 BBBP-Y (45) RFA Panel: Animal/Biological Resource Facilities Study Section (Scientific Review Group, SRG), 2015 US Department of Justice – Office of Justice Program. NIH Study Section, ZRG1 SSS-N 20 Special Emphasis Panel for Oncology Fellowship Review, October 30-31, 2000, July 12-13, 2001, October 29-30, 2001, July 22-23, 2002, November 8-9, 2004. Chair and Reviewer, NIH CSR Endocrinology, Metabolism, Nutrition and Reproductive Sciences Small Business/Technology Transfer (SBIR/STTR) Study Section, Special Emphasis Panel, NIH CSR ZRG1 EMNR-S 11 B, 12/2013. June 14th, 2018. 2018 NIH Grant Reviewer, Glycoscience UO1 ZRG1 IMST-B (52) R Study Section 2018 Grant Reviewer, Bloodwise (UK) 2018 NIH Grant Reviewer, Intercellular Interactions (ICI) Study Section 2018 Grant Reviewer, BWH BRI Pilot and Innovation Grants Program 2018 BWH/BRI Grant Review, Smith Family Awards - Excellence in Biomed. Study Section Computational Biophysics (ZRG1) Study Section: Ad Hoc Member: External: National: 2006: Advances in Biomolecular NMR Spectroscopy, Boston, MA. Applicant investigators and institutional officials must not communicate directly with study section members about an application before or after the. Director, UConn Neuroscience in Salamanca Spain Study Abroad. Applicant investigators and institutional officials must not communicate directly with study section members about an application before or after the review. Member 2010/05 ZDK1 GRB-6 (M1) 1 - Energy Balance Program Projects, National Institutes of Health. LaBar, Kevin S. Study Section. 3/14, DC; NIH, Study Section, Nanotechnology (NANO), 5/13 and 9/12, Special Emphasis Panel/Scientific Review Group ZRG1 ETTN-P -(50) R PAR-11-304, Development of Appropriate Pediatric Formulation and Drug Delivery Systems, 3/12, CA and NIH, Special Emphasis. 2004 Ad Hoc Reviewer, NIH Study Section for Fellowships in Systems and Cognitive Neuroscience (ZRG1-F02B) 2005-2008 Charter (“Permanent”) Member, NIH Sensorimotor Integration Study Section 2007 Member of NASA/NSBRI Study Section for Postdoctoral Research Proposals 2008, 2009 Chairperson, NIH Special Emphasis Panels for Auditory and. Member, Ad Hoc, Hepatobiliary pathophysiology (HBPP) study section, NIH, September, 2006. Study Section (ZRG1 F02B-D), October 2013, February 2014, February 2015 Member NIH special emphasis panel (ZRG1 IFCN-Q 55). Hatton Awards Committee Member, 2017 IADR/AADR Group Program Chair, Women in Science Network Group, 2017. • NIDCD Otitis media RFA-DC-02-002 Study Section, 2002 and 2003. ZRG1 EMNR-E 80 S, Diabetes, Obesity and Endocrine Disorders March 23, 2011-March 24, 2011 March 2011 Stage 1 Reviewer, NIH Director's Early Independence Award Application Review ZRG1 BBBP-E (53)R. Food and Drug Administration 2002-2005 Member, Education Committee, American Gastroenterological Association 2002- Editorial Board, Regulatory Peptides. AHRQ Review Study Section Jean-Pierre N. To study these mechanisms in detail, my lab has generated in vitro models of development and disease that recreate the three-dimensional and mechanical environments of in vivo tissues. 2017 Co-Chair, NIH Psychosocial Risk and Disease Prevention Study Section (PRDP), CSR Scientific Review Officer: Stacey Fitzsimmons. 23-24 NIH CSR NIGMS Special Emphasis Panel Review (2021-01 ZRG1 CB-D (55)) of MIRA. Chee Lim: 06/22/2021 : ZRG1 AIDC-S 80 Recurring SEP: Infectious Diseases and Immunology Research Enhancement Review : Dr. 2009 Grant Reviewer, NIH Study Section, SBIR/IMST-16, Cell Biology, Center for Scientific Review, National Institutes of Health, Bethesda, MD 2010 Ad-Hoc Reviewer, 2010/10 ZRG1 IMST-J (16) B Small Business: Cell Biology and Molecular Imaging. National Institute on Minority Health and Health Disparities. Jacobs School of Medicine & Biomedical Sciences. Session Chair, Methods in Statistical Genomics. National Institutes for Health (ZRG1 BST-J) Study Section Committee 2009. May 1998 Chairman, National Institutes of Health VISB Special Emphasis Panel ZRG1 07, teleconference. regulation and maintenance of constant internal conditions in…. Ad Hoc Expert Reviewer Cardiovascular Study Section, National Institutes of Health. 6/17-18/2014: Co-chair of the NCI study section on Cancer Drug Development & Therapeutics (CDDT, 2014/10 ZRG1 OTC-T (10) B). Integrated Review Groups (IRGs) are clusters of study sections based on scientific discipline. (UKGD) Study Section 2006 Member, ZRG1 RUS-A 51 1, NIDDK PAR 06 113, October 26-31 2006 Reviewer, Research Grant Management, South African Medical Research. Review, NIH: Behavior and Social Science Methods, ZRG1 HOP-D (50) July 2004 Member and Guest Chair, Special Emphasis Panel, Center for Scientific Review, NIH: HIV and Other Infections among Drug Users Involved with the Criminal Justice System, ZRG1 HOP-M (50) 2004-2005 Ad hoc Member, Community-Level Health Promotion Study Section (CLHP), NIH. 2012/10 NIH CMIB study section; 2013/3 NIH SEP ZRG1 IMM-C Autoimmune and Infectious Disease study section; 2014/5 NIH CMIB study section; 2014/7 NIH SEP ZRG1 IMMC02M study section; 2015/2 NIH SEP NIAID P01 initiative; 2015/5 NIH CMIB study section. See full list on nih. , Aug, 2004. Ad Hoc Member, National Institutes of Health Study Section, Biological Chemistry and Macromolecular Biophysics, Special Emphasis Panel on Computational Biophysics - 09/2008 Member, American Institute of Biological Sciences Review Panel, Neurotoxin Exposure and Treatment Research Program (US Army Medical Research and Materiel Command) - 06/2006. Phone: 860-679-2241. Study Section. Separate study sections will only review MIRA applications from NIs and ESIs in response to RFA-GM-16-003. 2000 Chairperson for Ad Hoc Review ZRG1 IFCN-1 Center for Scientific Review. March 2015 Member Grant Review Committee, National Institutes of Health (NIH): ZRG1 F15-P20 Surgical Sciences, Biomedical Imaging and Bioengineering Study Section October 2014 Member, Grant Review Committee, National Institutes of Health (NIH): III (Innate Immunity And Inflammation) Study Section. 2012/10 NIH CMIB study section; 2013/3 NIH SEP ZRG1 IMM-C Autoimmune and Infectious Disease study section; 2014/5 NIH CMIB study section; 2014/7 NIH SEP ZRG1 IMMC02M study section; 2015/2 NIH SEP NIAID P01 initiative; 2015/5 NIH CMIB study section. The Topics in Bacterial Pathogenesis Special Emphasis Panels [IDIA 80 and 81] are identical in scope and review applications that would otherwise be reviewed by either the Bacterial Pathogenesis (BACP) or Host Interactions with Bacterial Pathogens (HIBP) Study Sections. 2011 Bacterial Pa thogenesis Special Emphasis Panel, NIH -201201 ZRG1 IDM A80—October 20- 21, 2011. Applicant investigators and institutional officials must not communicate directly with study section members about an application before or after the review. 2017 Member, Special Emphasis Panel (Clinical Research and Pediatric Research LRP). NIH CSR Study Section ZRG1 IFCN-A (02) M. Member, National Institutes of Health, ZRG1 BST-X(40) Review Panel, P41 Biomedical Technology Research Resource - 03. 2015 K01 Study Section / BEST Study Section / P41 Study Section 2016 F31 Study Section 2016 NIH ZRG1 F10A Fellowship Reviewer November, Arlington, VA 2016 NIH ZRG1 BCMB-S (40) Study Section December, Champaign, IL 2016 Grant Reviewer for Dr. Biodemography Member. 1 was conducted before the current pandemic began. 2010 Fellow, American Heart Association. 2007 Ad hoc reviewer on Study Section of ZRG1 NOMD-A (Neural Oxidative Stress, Mitochondria and Cell Death), National Institute of Health 2007 Review Panel F, Alzheimer’s Disease Research Program, Department of Health Services,. 2005, Reviewer, NIH Center for Scientific Review Study Section CSR ZRG1-F12B (7/8-7/9/05) 2006, Reviewer, Journal of Family Psychology 2007, Reviewer, Special Emphasis Panel (SEP) for NIMH Centers for Pediatric Mental Health ZMH1-ERB-A (05) (6/21/07). 2015/10 NMSS Committee A; 2016/3 NIH SEP ZRG1-1 IMM-F 02; 2017/2 NIH CMIB study section. Phone: 716-645-4055. Member: National Institutes of Health ZEB1 OSR-D (M2) special emphasis panel (March. Greenberg, M. Gong K, Kung L-H, Magni G, Bhargava A, Jasmin L. Beginning January 26-27, 2012, Marina Del Rey. NIH - ZRG1 IDM W02 Study Section, Topics in Virology; Reviewer -mAd hoc (2020) JSMBS Faculty Council Steering Committee (2020-present) JSMBS Executive Committee (2020-present) Dean's Executive Committee (2020-present) Faculty Council Steering Committee (2020-present) PLOS Pathogens (2020) Journal of Virology (2020) PLOS One (2020). List of Reviewers on 03/19/2020; List of Reviewers on 11/07/2019; List of Reviewers on 06/03/2019. Biosensors, ZRG1 ETTN-C (10), 03/2018 NIH Study Section – Neuroscience and Ophthalmic Imaging Technologies (NOIT), 02/2016 NIH Special Emphasis Review Panel ZRG1 ETTN-L 53 R, PAR13-137: Bioengineering Research, 02/2016 NIH Special Emphasis Review Panel for National Heart, Lung, and Blood Institute, ZHL1 CSR-I (O1), 08/2014. If your application is getting reviewed at an IC, then you do not need to request a study section. Koman for the Cure Research Program. June 2014 Fellow. Reviewer Visual System Small Business Panel (ZRG1 BDCN-F) (12)), National Institutes of Health 2007 Ad Hoc Reviewer Visual Sciences A/Anterior Eye Disease Study Section, Visual Sciences Study Section, National Institutes of Health. Member, Special Emphasis NIH Review Panel, 10 ZRG1 IFCN -K (55) R, 2019. When pandemic arrived, some participants in the study got COVID-19 and others did not. Member, NIH/ CSR Study section ZRG1 IFCN-Z (02) 2015: Member, NIH/CSR Study Section ZRG1 IFCN- B-04M (October) Selected Publications. 2000-2008 Member, ZRG1 F10 Study Section, NIDDK 2000-2003 Member, GI Advisory Committee, U. [ZRG1 CVRS-H (11) B] reviews Small Business Innovation Research (SBIR) and Small Business Technology Transfer Research (STTR) grant applications involving. National Institutes of Health (NIH) Academic-Industrial. 2010 EU FP7 HEALTH 2010: Identifying new therapeutic targets for atrial fibrillation. 2013 • NIH Study Section, NIDA 2013/05 ZRG1 DTCS-A (81) S. Member 2010/05 ZDK1 GRB-6 (M1) 1 - Energy Balance Program Projects, National Institutes of Health. 2002 2006: Member, Medicinal Chemistry (MCHA/SBCA) Study Section. CSR organizes the peer review groups or study sections that evaluate the majority (75%) of the research grant applications sent to NIH. 06/14/10-06/15/10 NIH Cancer Etiology Study Section. 2001-2003 Member of the Harbor Consortiu m by New York Academy of Science and New York City Health Department. Fei served as the Chair for the National Institute of Health (NIH) Study Section ZRG1 SBIB-J (56) on Imaging and Image-guided Interventions and as co-Chair for multiple NIH and Department of Defense (DOD) Study Section Panels. Applicant investigators and institutional officials must not communicate directly with study section members about an application before or after the review. Temporary member of NTRC study section (NIH), 2009, February and October meetings Ad hoc, mail reviewer, ZRG1 MDCN A (NIH, challenge grants), 2009 NIH Special Emphasis Panel (SEP, MDCN-A(05)M) teleconference, March 2011 NIH Special Emphasis Panel (ZRG1 MDCN-N 04) teleconference, June 2012. 2009 Grant Reviewer, NIH Study Section, SBIR/IMST-16, Cell Biology, Center for Scientific Review, National Institutes of Health, Bethesda, MD 2010 Ad-Hoc Reviewer, 2010/10 ZRG1 IMST-J (16) B Small Business: Cell Biology and Molecular Imaging. NIH - ZRG1 IDM W02 Study Section, Topics in Virology; Reviewer -mAd hoc (2020) JSMBS Faculty Council Steering Committee (2020-present) JSMBS Executive Committee (2020-present) Dean's Executive Committee (2020-present) Faculty Council Steering Committee (2020-present) PLOS Pathogens (2020) Journal of Virology (2020) PLOS One (2020). For example, enter "CAMP" for the Cancer Molecular Pathobiology study section or enter text formatted like "ZRG1 HDM-R (11) B" for an SBIR/STTR panel. Santa Barbara, CA 2013: Chair, Special Emphasis NIH Study Section ZAG1 ZIJ. Mock Study Section on Friday, April 3rd from 8 a. Contact Information. com and suggest new type of analysis. 2010-2014 Chair of Brain 3, AHA National Innovative Research Grant (IRG) study section 2013-2019 NIH ZRG1 CMBG study section, regular member 2015-present AHA Peer Review Committee member, Brain 3 2015-present Dept. 101, San Francisco, CA 94110 Phone: 415-206-3708. 2012: Member, NIH/NIMHD/CSR Research Program (RO1) Study Section ZMD1 MLS (01) 2012: Ad Hoc Member, NIH/NHLBI/CSR Special Emphasis Panel 2012/10 ZRG1 VH-D (90) S: Vascular and Hematology 2011-2016: Regular Member, AHA Vascular Endothelial Biology and Function Study Section. Service Performed By. Allergy and Immunology (ALY, now CMI-A) Study Section, 1984 - 2000 Immunological Sciences (IMS, now TTT) Study Section, 1985 - 1988 Education Committee, American Association of Immunologists, 1988 - 1992 ZRG1 BDCN-B (55) Review panel for Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimer. June 14th, 2018. 215E Bonner Hall. Koman for the Cure Research Program. Study Section. Emphasis is on statistical quantitative methods to aid in. Member for NIH MSFA study section (2020-2024) ad hoc reviewer for NIH panels ZRG1 Study Section (Small Business: Biological Chemistry and Biophysics) 2016 and 2018. For example, you would enter CAMP if you wish to request assignment to the Cancer Molecular Pathobiology study section or enter ZRG1 HDM-R if you wish to request assignment to the Healthcare Delivery and Methodologies SBIR/STTR panel for informatics. Member, Scientific Advisory Board, Glenn Foundation for Medical Research. Ad-Hoc Reviewer for National Institutes of Health and others: 2008: NIH study section (ZDA1); 2009: NIH (ZRG1); 2009 NIH (ZRG1); 2011 NIH (ZRG1 F03B); 2012 NIH (ZGM1-TRN-C); 2013 NIH (ZRG1 BDCN-N 58); 2014-2017 American Heart Association (AHA) (Brain 2); 2018-2019 AHA (Transformational Project Award); 2019 NIH (ZRG1 BDCN-L90); 2019 NASA (The. 2017 Scientific Reviewer, Society of Behavioral Medicine Abstract Review Committee. 2016 Member, Research Resource for Microscopy Image Data Analysis (ZRG1 BST-H (40)). Chair, Special Emphasis Review NIAID Panel, 2015. 3/14, DC; NIH, Study Section, Nanotechnology (NANO), 5/13 and 9/12, Special Emphasis Panel/Scientific Review Group ZRG1 ETTN-P -(50) R PAR-11-304, Development of Appropriate Pediatric Formulation and Drug Delivery Systems, 3/12, CA and NIH, Special Emphasis. 2017 Chair, NIH, Psychosocial Risk and Disease Prevention (ZRG1 RPHB) Study Section, CSR Scientific Review Officer: Weijia Ni. AHRQ Review Study Section Jean-Pierre N. Failure to observe this policy will create a serious breach of integrity in the peer review process,. 7 : Special panel ZRG1 DKUS-K11 2009. Chair, NIAID ZRG1 IMM-S (90)S Study Section, 2016. Name Brown University. LI, SHULIN, PHD PROFESSOR. 2010 Service or Event Name. 2001 - 2006 - Member of the National Institute of Health Grant Review Study Section - Brain Disorders and Clinical Neuroscience 1 (BDCN-1/CND) October 2003 - Invited Participant -NIH-NINDS - Priorities for Clinical Research in the Treatment of Acute, non-Traumatic Intracerebral Hemorrhage Workshop, 2003. Failure to observe this policy will create a serious breach of integrity in the peer review process, and may lead to actions outlined in NOT-OD-14-073 and NOT-OD-15-106 , including removal. Ad hoc Study section NIH Special Emphasis Panel, Pathogenic Eukaryotes (PTHE). NIH study section Drug Discovery and Probes for the Nervous System ZRG1 MDCN B from BIOLOGY 3040 at Boston College. 2012 Member, NIGMS National Centers for Systems Biology (ZGM1-CBB--MI) 11/2012. Member, Special Emphasis NIH Review Panel, 08 ZRG1 IFCN -K (56) R, 2019. 2010 Member, Enabling Bioanalytical and Imaging Technologies (ZRG1-IMST-J) 9/2010 2009 Member, NIGMS Competitive Revision (ZGM1 CBCB-4 (RA)) Study Section 4/2009 2009 Member, NIGMS National Centers for Systems Biology (ZGM1) Study Section 4/2009 2008 Member, Microscopic Imaging (MI) Study Section 12/2008. Chair: National Institutes of Health ZRG1 BST-T (02) special emphasis panel (November 2015). Chairman, Pathobiology Kidney Disease Study Section: ZRG1 DKUS-A (Aug 22, 2011) Adhoc, NIH/NHLBI Program Project, December 14, 2011 Expert Panel, NIDDK AKI Outcomes: Overcoming the Barriers in Acute Kidney Injury 2015. Member, ZDK1 GRB-4 M, 2005. Neuroimmunology and Spinal Cord Injury ZRG1 BDCN-Y(02) 2011. Be careful to accurately capture all formatting (e. 2009 NIH study section. NIH GHD ad hoc study section member, October 10-11, 2009. Applicant investigators and institutional officials must not communicate directly with study section members about an application before or after the. 2013: ZAI1 LR -M (P01 program project grant), ZRG1 IMST L. 2000-2008 Member, ZRG1 F10 Study Section, NIDDK 2000-2003 Member, GI Advisory Committee, U. PBKD Study Section 2007. 23-24 NIH CSR NIGMS Special Emphasis Panel Review (2021-01 ZRG1 CB-D (55)) of MIRA. Friedreich's Ataxia Research Alliance (FARA) grant review (2014). Then enter the short abbreviation for that study section in the boxes for "Suggested Study Sections. [email protected] 2015 K01 Study Section / BEST Study Section / P41 Study Section 2016 F31 Study Section 2016 NIH ZRG1 F10A Fellowship Reviewer November, Arlington, VA 2016 NIH ZRG1 BCMB-S (40) Study Section December, Champaign, IL 2016 Grant Reviewer for Dr. NIH Study Section – ZRG1 PSE-P 03 M NIA Special Emphasis Panel (2017) NIH Study Section - ZCA1 SRB-8 (M1) NCI Omnibus R03 & R21 SEP-9 (2016) The India Alliance – Fellowship for senior investigators, Reviewer (2016) Department of Defense Army Research Office, Reviewer (2012) NIH Study Section – ZRG1 IMST-C30 (S10 applications) (2009). Study Sections. Science Foundation Ireland (Fonduireacht Eolaiochta Eireann), SFI. See our Locus of Review FAQ for more information. 2000 Ad Hoc Reviewer, ZRG1 IFCN-1(03) CSR Special Emphasis Panel, National Institute of Health, Bethesda, Maryland. 07/22/10 NIH Special Emphasis Panel on Fellowship (ZRG1 F04B-B 20 L) 02/28/11-02/28/11 NIH Cancer Etiology Study Section. Greenberg 5 16. 2003-2004 Member, Respiratory Physiology (RESP) Study Section, NIH 2003 Ad Hoc Member, Special Emphasis Panel (ZRG1 CII 04, Drug Resistance), NIH 2003-2006 Member, Respiratory Integrative Biology and Translational Research (RIBT) Study Section, NIH 2004 Ad Hoc Member, Special Review Committee (ZRG1 MOSS D04 for Muscle Related. Chair, ZRG NMB, Neurotoxicology of Heavy Metals Study Section, 2004. In addition he is the Director of Center for Integrative Toxicology. ZAI-EC-M-S1 Study Section. • Senior Research Fellow and Director, Neurology Section, Neuroscience Therapeutics; December, 1999-April, 2000 • Senior Research Fellow and Group Leader, Neuropharmacology, Neuroscience Therapeutics. 2000-04 Study Section Member, for Cell Development and Function-4 (CDF-4) NIH/NIGMS. 2000 Special Reviewer, Pathobiochemistry Study Section 2002- Member, NIH Special Emphasis Review Panel (ZRG1 BIO) 2003 Tumor Microenvironment Study Section, NIH 2006-08 Special Emphasis Panel Reviewer, NIHLB, NIH 2008 Member, External Review Panel for Molecular Biology Section, NIDCR, NIH 2009 Special Emphasis Panel/Scientific Review Group 2010. Gong K, Kung L-H, Magni G, Bhargava A, Jasmin L. 2020 Ad hoc NIH ZRG1 CBA (50) study section panel member 2020 Ad hoc NIH NCSD study section panel member 2019 Reviewer for NSF MCB Genetic Mechanisms. The research team wanted to use their data to determine whether probability of getting COVID depends on a person’s sex, where they live, and also the diversity of their lung microb i ome. 2001: Medicinal Chemistry (Spring, Fall);. SERVICE ON NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS, COMMITTEES: - Ad hoc reviewer EVR Study Section, NIH 2002 – 2003. 2004 Reviewer for CSR special emphasis panel ZRG1 BST-D (40) for biomedical technology resource grant (NIH P41) (Old Town, VA, April 7-8). 2001 - 2006 - Member of the National Institute of Health Grant Review Study Section - Brain Disorders and Clinical Neuroscience 1 (BDCN-1/CND) October 2003 - Invited Participant -NIH-NINDS - Priorities for Clinical Research in the Treatment of Acute, non-Traumatic Intracerebral Hemorrhage Workshop, 2003. NIH - ZRG1 IDM W02 Study Section, Topics in Virology; Reviewer -mAd hoc (2020) JSMBS Faculty Council Steering Committee (2020–present) JSMBS Executive Committee (2020–present) Dean's Executive Committee (2020–present) Faculty Council Steering Committee (2020–present) PLOS Pathogens (2020) Journal of Virology (2020) PLOS One (2020). Separate study sections will only review MIRA applications from NIs and ESIs in response to RFA-GM-16-003. Menon/CV 4 2017 Member, NIMH Study Section (SEP ZRG1-BBBP-Y-02). Study Section Study Section Description Scientific Review Officer Date; ZRG1 ACTS-L 07 Oct 2021 Arthritis, Connective Tissue and Skin Sciences : Dr. July 2017 Study Section, ZRG1 DKUS J, Physiological & Pathological Sciences. Reviewer for NIH/NIGMS Study Section ZRG1 BDMA (Biodata management and analysis): Mar 2004, Jun 2004. - Permanent Member Virology B Study Section, NIH, 2/2004-6/2006. United Mitochondrial Disease Foundation study section co-chair (2011-2015), NIH ZRG1 ETTN-G (2013), Chronic Fatigue Initiative review panel (2014-2015). The study section was ZRG1 AARR-K (56); 08/06/2018; in response to PAR-17-340: Collaborative Program Grant for Multidisciplinary Teams. 2008 NIH Special Emphasis Panel ZRG1 HOP-V (02) M Ad hoc Member 2009 NIH Challenge Grant Review Panel #10 ZRG1 BDA-A (58) Ad hoc Member 2009 NIH Special Emphasis Panel ZRG1 PSE-E (02) M Ad hoc Member 2009 NIH Special Emphasis Panel ZAG1 ZIJ-9 (J4) Ad hoc Member 2010 NIH Neurological, Aging and Musculoskeletal Epidemiology study section. December, 1997-December, 1999 • Adjunct Professor of Pharmacology, Northeastern Ohio Universities College of Medicine. Review, NIH: Behavior and Social Science Methods, ZRG1 HOP-D (50) July 2004 Member and Guest Chair, Special Emphasis Panel, Center for Scientific Review, NIH: HIV and Other Infections among Drug Users Involved with the Criminal Justice System, ZRG1 HOP-M (50) 2004-2005 Ad hoc Member, Community-Level Health Promotion Study Section (CLHP), NIH. Study Section Special Emphasis Panel (ZRG1) Program Officer Damico, Mark W. Empire Innovation Professor. STTR Study Section, Jun 24-26 2009 NIH 2009 ZRG1 IDM-C (58) Challenge Grant Study Section; NIH 2009 ZRG1 IMM-E (58). National Academies Keck Futures Initiative Healthspan Seed Grant Review Working Group. Phone: 860-679-2241. Member, Special Study Section 7, National Institutes of Health (1995) Member Ad hoc, Biophysical Chemistry Study Section BBCB, NIH (1996) Member, NIH Special Emphasis Review Panel, ZRG1 SSS-A (2002) Member, NIH Special Emphasis Panel, ZRG1 BPC-L 30, NMR S10 (2004) Member, NIH Special Emphasis Panel, ZRG1 F04B 20 L, Fellowships (2005). Member, Special Emphasis NIH Review Panel, 10 ZRG1 IFCN -K (55) R, 2019. NIH, ZRG1 F05 study section reviewer (NRSA Fellowships in Cell Biology and Development) (2005, 2007, 2008) Austrian Science Fund (FWF - Fonds zur Förderung der Wissenschaftlichen Forschung Biologie & Medizin) proposal reviewer (2006) NIH, BDPE study section reviewer (2005). Academic Office Location: Neuroscience. Meeting Roster - ZRG1 BCMB-N 50 (04/10/2018 - 04/12/2018) Notice of NIH Policy to All Applicants: Meeting rosters are provided for information purposes only. Internal Grant Reviewer for National High Magnetic Field Laboratory (NHMFL), Florida. Using a flexible biofabrication system, we have generated dynamic, 3D models of myocardial, valvular, and vascular histogenesis. NIH GHD ad hoc study section member, October 10-11, 2009. 2011, 13, 14 Grant Reviewer, Israel Science Foundation. The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. 2016 Member, Research Resource for Microscopy Image Data Analysis (ZRG1 BST-H (40)). 2012 Ad-Hoc Reviewer, ZRG1 IDM-R (02) M (Parasites and Vectors Study Section), National Institutes of Allergy and Infectious Disease 2012 External Grant Reviewer, Rhode Island Research Alliance Collaborative Research. See our Locus of Review FAQ for more information. 2001: Medicinal Chemistry (Spring, Fall);. 2000-04 Study Section Member, for Cell Development and Function-4 (CDF-4) NIH/NIGMS. 1985 - 1987 Research Associate, Section of Physical Anthropology, IVPP,. LIFESPAN)” Study Section, Nov 2011- Jan 2012 NIH Director’s Pioneer Award Study Section, Dec 2011 - Jan 2012 Co-Chair, NIH ZRG1 PSE-K (03) Social Science and Population Studies SEP, Sept-Oct 2011. Failure to observe this policy will create a serious breach of integrity in the peer review process, and may lead to actions outlined in NOT-OD-14-073 and NOT-OD-15-106 , including removal. Member, Neurotoxicity and Alcohol Study Section, 2006. 2017/01 ZAI1 JRR-M (J1) Special Emphasis Panel. Member, Government and Public Affairs Committee, Society for Neuroscience, 2017- present. 2009- NIH, NHLBI Special Emphasis Panel, ZRG1 CVRS-B (58) R. Chair, ZRG NMB, Neurotoxicology of Heavy Metals Study Section, 2004. , spaces, hyphens) when you type in the request. Freelander Chair in AIDS Research and Professor, Program in Molecular Medicine and Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School. 2001 Gender Equity Award for promoting a gender-fair environment for the education and training of women physicians and assuring equal opportunity for women and men to study and practice medicine. , spaces, hyphens) when you. Professor of Psychology and Neuroscience Role. in Portland, Oregon. 06/14/10-06/15/10 NIH Cancer Etiology Study Section. Failure to observe this policy will create a serious breach of integrity in the peer review process,. Separate study sections will only review MIRA applications from NIs and ESIs in response to RFA-GM-16-003. Or e-mail [email protected] The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. Member, ZRG1 IMM, 2005. Reviewer for NIH/NIGMS Study Section ZRG1 BPC‐Q and BCMB‐N (Computational biophysics): Oct 2004, Feb 2005, Feb 2007. investigators and institutional officials must not communicate directly with study section members about an application before or after the review. Today, as the flagship of the state's 13-campus university system, University of Maryland, College Park is home to more than 41,000+ students, 4,440+ faculty, and 250 academic programs. 4/2015 ZHD1 DSR-Y (MC) 1 study section 10/2014, 2/2015 NCF study section, Co-Chair 2011 NCF study section, regular member 09/2010 ZRG1 MDCN-T (03) 10/2009 DBD study section 09/2009 ZRG1 BDA-A (52)R study section 06/2009 ZRG1 MDCN-F (95)s study section 06/2009 NDPR study section 03/2009 NSD-A study section 04/2008 CHHD-C. Wasted potential - How many "promising postdocs" actually get R01 grants? San Francisco wins - Comparison of the money obtained from NIH for East & West coast. Friedreich's Ataxia Research Alliance (FARA) grant review (2014). Schwartz spent a year at Yale-New Haven Medical Center receiving advanced fellowship training. Member, Special Study Section 7, National Institutes of Health (1995) Member Ad hoc, Biophysical Chemistry Study Section BBCB, NIH (1996) Member, NIH Special Emphasis Review Panel, ZRG1 SSS-A (2002) Member, NIH Special Emphasis Panel, ZRG1 BPC-L 30, NMR S10 (2004) Member, NIH Special Emphasis Panel, ZRG1 F04B 20 L, Fellowships (2005). October 2014 AD hoc member NIH Mechanisms of Sensory, Perceptual, and Cognitive Processes (SPC) Study Section, June 2014 Referee Grants: National Science Foundation, National Institutes of Health,. 03/16 - 11/18 Reviewer for NIH ZRG1 SBIB Z-58 R Study Section 2/17 Reviewer for NIH SPARC OT2 Study Section 08/10 - 12/16 Reviewer for NIH Small Business Medical Imaging Study Section. 2005-2006 International reviewer for Cancer Research UK. Chairman, Pathobiology Kidney Disease Study Section: ZRG1 DKUS-A (Aug 22, 2011) Adhoc, NIH/NHLBI Program Project, December 14, 2011 Expert Panel, NIDDK AKI Outcomes: Overcoming the Barriers in Acute Kidney Injury 2015. All questions should be directed to the Scientific Review Officer in charge of. Reviewer for NIH/NIGMS Study Section ZRG1 MOSS D14: June 2005 4. Greenberg 5 16. 2004 Reviewer for CSR special emphasis panel ZRG1 BST-D (40) for biomedical technology resource grant (NIH P41) (Old Town, VA, April 7-8). June 12-13, 2008 – Oncological Sciences Integrated Review Group for Developmental Therapeutics Study Section October 20, 2006 – Special Emphasis Panel on “Polymers and Probes” – ZRG1 BST-A(02) (Role: Member). 2011 Member, Mail Reviewer, NIH K99 review panel. NIH HAI ad hoc study section member, February 4-5, 2010 NIH ZRG1 IMM-J(02)M Special Emphasis Panel, June 9, 2010 PRMRP 2010 Concept Awards, July 2010 Medical Research Council (UK) G1001193, August 2010 PRMRP 2011 Lupus Panel, September 7, 2011. Empire Innovation Professor. Study Section Special Emphasis Panel (ZRG1-SSS-C (29)) Program Officer Boyce, Cheryl A. Challenge Grant Study Section; NIH 2009 ZRG1 IDM-Q (10) B SBIR. Name Brown University. 4/2015 ZHD1 DSR-Y (MC) 1 study section 10/2014, 2/2015 NCF study section, Co-Chair 2011 NCF study section, regular member 09/2010 ZRG1 MDCN-T (03) 10/2009 DBD study section 09/2009 ZRG1 BDA-A (52)R study section 06/2009 ZRG1 MDCN-F (95)s study section 06/2009 NDPR study section 03/2009 NSD-A study section 04/2008 CHHD-C. 8 : Special panel ZRG1 DKUS-G 03, 2009. Stage 1 Reviewer, National Institutes of Health Challenge Grant applications for ZRG1 PSE-J and ZRG1 PSE-C. The research team wanted to use their data to determine whether probability of getting COVID depends on a person’s sex, where they live, and also the diversity of their lung microb i ome. NIH, ZRG1 F05 study section reviewer (NRSA Fellowships in Cell Biology and Development) (2005, 2007, 2008) Austrian Science Fund (FWF - Fonds zur Förderung der Wissenschaftlichen Forschung Biologie & Medizin) proposal reviewer (2006) NIH, BDPE study section reviewer (2005). Ad hoc member, Targeted Therapies (2) study section- 03/2009; National Institutes of Health.